STAT3 and non-small cell lung carcinoma: The conclusion based on the experimental results was that STAT3 silenced non-small cell lung cancer (NSCLC) cells exhibit enhanced pro-inflammatory chemokine production, reduced MHCI antigen expression, and increased sensitivity to NK cell-mediated cytotoxicity [49].